Humacyte, Inc. (HUMA)
(Delayed Data from NSDQ)
$3.99 USD
+0.09 (2.31%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.98 -0.01 (-0.25%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Humacyte, Inc. (HUMA) reported earnings of -$0.24 per share, beating the Zacks Consensus Estimate of $-0.25 per share. This reflects a positive earnings surprise of 4.00%. Look out for HUMA's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year decrease of 4.55%.
Earnings History
Price & Consensus
Zacks News for HUMA
Humacyte (HUMA) Up on HAV BLA Priority Tag for Vascular Trauma
HUMA: What are Zacks experts saying now?
Zacks Private Portfolio Services